Get the Full Story, Without the Noise.
Published loading...Updated

US anesthesia and respiratory devices market faces disruption as tariffs drive supply chain shift: GlobalData

Summary by Express Healthcare
The US anesthesia and respiratory (A&R) devices market faces major disruption as new US tariffs hit foreign-made products, with majority of all 510(k) approved devices manufactured outside the country. This raises serious supply chain concerns and may shift market dynamics in favor of domestic manufacturers, even as the market grows from $4.4 billion in 2023 to a projected $7.5 billion in 2033, according to GlobalData. An analysis of GlobalData’…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

5 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GlobalData broke the news in on Wednesday, May 7, 2025.
Sources are mostly out of (0)